The global COVID-19 pandemic has put the entire scientific and medical community to test with the urgent need to understand this novel virus (SARS-CoV-2) and the new disease (COVID-19).1,2While the diagnostic industry has responded to the call in a record speed and gained substantial information, an emerging focus is to understand whether patients recovered from COVID-19 will develop protection or immunity.3,4 Knowledge about acquired immunity to COVID-19 not only provides valuable insights for the development of vaccines and therapeutics but also enable the implementation of suitable policies and strategies for effective pandemic control.5,6
Click here to read more about how neutralizing antibodies are an important mechanism to immunity for SARS-CoV-2.
2. Coronavirus (COVID-19) – CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html
3. Interpreting Diagnostic Tests for SARS-CoV-2, N Sethuraman, et al, JAMA Published online May 6, 2020, DOI: 10.1001/jama.2020.8259
4. Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection? J Gil Melgaçoa, et al, Cellular Immunology 353 (2020) 104114, https://doi.org/10.1016/j.cellimm.2020.104114
5. “Immunity passports” in the context of COVID-19, Scientific Brief, https://www.who.int/news-room/commentaries/detail/immunity-passports-in-the-context-of-covid-19
6. Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2) and Implications for Vaccines, C Manners, et al, Cureus 12(6), 2020: e8399. DOI 10.7759/cureus.8399